$120.85$150.99
Prepare to embark on a sensory journey with the Bosco Apple, a fruit that transcends the ordinary and promises an unparalleled taste experience. These apples are nothing short of nature’s masterpiece, celebrated for their distinctive blend of flavors and their captivating visual allure.
Availability: In Stock
Subscribe to out newsletter today to receive latest news administrate cost effective for tactical data.
₹989
INTRODUCTION BRINTOP 5% TOPICAL SOLUTION contains Minoxidil which belongs to the group of medicines called Vasodilators. It is used to treat hereditary hair loss (androgenic alopecia) on the head in men and women. Androgenic Alopecia affects the hair present in the crown and the front portion...
BRINTOP 5% TOPICAL SOLUTION contains Minoxidil which belongs to the group of medicines called Vasodilators. It is used to treat hereditary hair loss (androgenic alopecia) on the head in men and women. Androgenic Alopecia affects the hair present in the crown and the front portion of the scalp. It is caused mainly due to hormonal imbalance and it is characterized by baldness and thinning of the hair. BRINTOP 5% TOPICAL SOLUTION is used to treat only mild to moderate hair loss problems, not complete hair loss and helps to stimulate hair growth in such cases.
BRINTOP 5% TOPICAL SOLUTION is not to be used in cases of the pattern of your hair loss differs from a receding hairline and crown balding, have no family history of hair loss, have total baldness or complete loss of all body hair, have inflamed, infected, irritated or painful scalp, have any condition that affects your scalp such as sunburn and psoriasis and are currently taking other medications that are being applied on the scalp. Consult your doctor for a proper physical examination of the scalp before using this medicine.
BRINTOP 5% TOPICAL SOLUTION is not recommended for use in pregnant women or those who are planning to get pregnant, breastfeeding women, children less than 18 years of age as well as elderly individuals over 65 years of age.
The most common side effects of applying BRINTOP 5% TOPICAL SOLUTION are headache, itching of the scalp, rash, burning sensation and excessive hair growth. Consult your doctor in case any of the side effects worsen or persist for long.
BRINTOP 5% TOPICAL SOLUTION regrows hair and stabilizes hair loss in men with a receding hairline and head balding by the revitalization of hair follicles. Revitalization of hair follicles is by BRINTOP 5% TOPICAL SOLUTION vasodilatory action that helps to increase the blood flow when applied to the scalp. This increased blood flow helps to provide more nutrition and oxygen to the hair follicles thus preventing hair cell death and enhancing new hair growth.
Always use BRINTOP 5% TOPICAL SOLUTION as directed by your physician. It is for external use only. This medicine is for use on the normal healthy scalp only. Apply BRINTOP 5% TOPICAL SOLUTION directly on dry scalp and hair. Do not use it on inflamed, infected, irritated or painful scalp skin. Do not apply to any other parts of the body. Avoid contact with your eyes. Your doctor will decide the required dose and duration of BRINTOP 5% TOPICAL SOLUTION for you as per your age and disease condition.
Stop using BRINTOP 5% TOPICAL SOLUTION and contact your doctor immediately if you experience any of the following side effects:
Headache:
Drink ample amount of water and avoid skipping meals. Get adequate rest. Try to be relaxed and stress-free. Consult your doctor regarding your symptoms and take medicine accordingly.
BRINTOP 5% TOPICAL SOLUTION is not recommended for use in pregnant women and in women who are trying to get pregnant. Consult your doctor before using BRINTOP 5% TOPICAL SOLUTION.
BRINTOP 5% TOPICAL SOLUTION is not recommended for use in breastfeeding women. Consult your doctor for advice.
Do not drive or operate any machines if you feel dizzy or experience low blood pressure after using BRINTOP 5% TOPICAL SOLUTION.
Do not use BRINTOP 5% TOPICAL SOLUTION if you are allergic to minoxidil or any other ingredients of this medicine.
BRINTOP 5% TOPICAL SOLUTION is not recommended for use in patients suffering from high blood pressure and must be used with caution in patients suffering from abnormal heart rhythms or rates, chest pains or circulation disorders. Consult your doctor before using BRINTOP 5% TOPICAL SOLUTION.
BRINTOP 5% TOPICAL SOLUTION is not recommended for use if:
Use in pediatrics:
BRINTOP 5% TOPICAL SOLUTION is not recommended for use in children and adolescents below 18 years of age. Consult your child’s doctor for advice.
Use in geriatrics:
BRINTOP 5% TOPICAL SOLUTION is not recommended for use in elderly patients (aged 65 years and above). Consult your doctor before using BRINTOP 5% TOPICAL SOLUTION.
A. Drug-Drug interactions:
Before using BRINTOP 5% TOPICAL SOLUTION, inform your doctor if you are taking any of the following medicines:
Overdosage:
If you or anyone else accidentally use too much of [GBNKEYWORD on a larger area of skin or on an area other than the scalp or on damaged skin (due to trauma, inflammation or a diseased condition), it may cause a systemic effect then contact your doctor immediately. Symptoms of BRINTOP 5% TOPICAL SOLUTION overdose include cardiovascular reactions such as low blood pressure, rapid heart rate and lethargy.
| Drug | : | Minoxidil |
| Pharmacological Category | : | Vasodilators |
| Therapeutic Indication | : | High blood pressure (hypertension) |
| Dosage Forms | : | Tablet, Cream, Foam, Gel, Hair serum, Spray, Topical solution, Lotion, Roll-on solution |
What is BRINTOP 5% TOPICAL SOLUTION used for?
BRINTOP 5% TOPICAL SOLUTION contains Minoxidil which belongs to the group of medicines called vasodilators. It is used to treat hereditary hair loss (androgenic alopecia) on the head in men and women. Androgenic Alopecia affects the hair present in the crown and the front portion of the scalp. It is caused mainly due to hormonal imbalance and it is characterized by baldness and thinning of the hair. BRINTOP 5% TOPICAL SOLUTION is used to treat only mild to moderate hair loss problems and not complete hair loss and helps to stimulate hair growth in such cases.
How to use BRINTOP 5% TOPICAL SOLUTION?
Always use BRINTOP 5% TOPICAL SOLUTION as directed by your physician. It is for external use only. This medicine is for use on the normal healthy scalp only. Apply BRINTOP 5% TOPICAL SOLUTION directly on dry scalp and hair. Do not use it on inflamed, infected, irritated or painful scalp skin. Do not apply to any other part of the body. Avoid contact with your eyes. Your doctor will decide the required dose and duration of BRINTOP 5% TOPICAL SOLUTION for you as per your age and disease condition.
Can BRINTOP 5% TOPICAL SOLUTION cause loss of hair after use?
In the first couple of months, BRINTOP 5% TOPICAL SOLUTION may cause increased hair shedding after use in some individuals. There is a temporary increase in the shedding of hair that generally occurs between 2 and 6 weeks after the start of treatment and then decreases. If increased shedding continues after 6 weeks of BRINTOP 5% TOPICAL SOLUTION use, consult your doctor.
How long should I use BRINTOP 5% TOPICAL SOLUTION?
Since hair grows slowly, BRINTOP 5% TOPICAL SOLUTION takes time to work. Results may be seen in 2-4 months with daily use. If there’s no hair regrowth after 4 months, then consult your doctor. The amount of hair regrowth is different for each person and may not work for all. Continued use of BRINTOP 5% TOPICAL SOLUTION is necessary to increase and maintain hair re-growth or hair loss will begin again.
What are the common side effects of using BRINTOP 5% TOPICAL SOLUTION?
The most common side effects of applying BRINTOP 5% TOPICAL SOLUTION are headache, itching of the scalp, rash, burning sensation and excessive hair growth. Consult your doctor in case any of the side effects worsen or persist for long.
When should I avoid using BRINTOP 5% TOPICAL SOLUTION?
BRINTOP 5% TOPICAL SOLUTION is not to be used in cases of the pattern of your hair loss differs from a receding hairline and crown balding, have no family history of hair loss, have total baldness or complete loss of all body hair, have inflamed, infected, irritated or painful scalp, have any condition that affects your scalp such as sunburn and psoriasis and are currently using other medications that are being applied on the scalp. Consult your doctor for a proper physical examination of the scalp before using BRINTOP 5% TOPICAL SOLUTION.
What if I accidentally ingest BRINTOP 5% TOPICAL SOLUTION?
Accidental ingestion of BRINTOP 5% TOPICAL SOLUTION may cause serious cardiac adverse events related to low blood pressure such as chest pain, rapid heartbeat, fainting, dizziness, sudden unexplained weight gain or swollen hands and feet. Consult your immediately if any such symptom arises. Keep BRINTOP 5% TOPICAL SOLUTION out of the reach of children to avoid such accidents.
1. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. Page – 2592-2596.
2. Ghonemy, Soheir, Abeer Alarawi and Hagar Bessar. Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation. National Library of Medicine, National center for biotechnology information.Pubmed.gov.2021. [Accessed on 5th July 2022] https://pubmed.ncbi.nlm.nih.gov/31403367/
3. Suchonwanit, Poonkiat, Sasima Thammarucha and Kanchana Leerunyakul. Minoxidil and its use in hair disorders: a review. National Library of Medicine, National center for biotechnology information. Pubmed.gov. 2019. [Accessed on 5th July 2022] https://pubmed.ncbi.nlm.nih.gov/3549810/
4. Janssen-Cilag. Regaine 50 mg/mL skin solution (Minoxidil). [Revised in November 2021] [Accessed on 5th July 2022] https://www.ravimiregister.ee/Data/PIL_ENG/PIL_8824_ENG.pdf
5. Janssen-Cilag. Minoxidil 2% Scalp solution. [Revised in November 2020] [Accessed on 5th July 2022] https://www.regaine.co.uk/sites/regaine_uk/files/pil.102.pdf
6. Rogaine 50 mg/g, cutaneous foam (Minoxidil). Package leaflet. [Revised in July 2018] [Accessed on 5th July 2022] https://docetp.mpa.se/LMF/Rogaine%20cutaneous%20foam%20ENG%20PL_09001bee807a80a1.pdf
7. Wrafton Laboratories Limited. Electronic Medicine Compendium (EMC). [Revised in April 2017] [Accessed on 5th July 2022] https://www.medicines.org.uk/emc/files/pil.8303.pdf
8. Proel Pharmaceutical Industry . Minoxidil/Target 5% w/v cutaneous solution. [Revised in December 2012] [Accessed on 5th July 2022] https://www.targetpharma.gr/wp-content/uploads/2017/10/Minoxidil_Target_EN_PIL_2661901_v4_en.pdf
Written By Dr. R. Dinesh John Rajkumar, Pharm.D
Last updated on 12 Oct 2022 | 06:31 PM(IST)